相关临床试验
0
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无批准数据
- A hantavirus outbreak aboard the MV Hondius cruise ship has resulted in 11 reported cases and three deaths worldwide, with the Andes virus strain confirmed in multiple patients. - Dr. Stephen Kornfeld, an oncologist who cared for sick passengers, has been cleared from Nebraska's biocontainment unit after inconclusive test results and is now asymptomatic. - WHO epidemic expert Maria Van Kerkhove emphasized that this is "not the next COVID" but remains a serious infectious disease requiring early clinical intervention for improved survival. - Health authorities across multiple continents are conducting contact tracing, with 42 contacts in South Africa testing negative and passengers remaining under 42-day quarantine protocols.
- The recent FDA approval of nogapendekin alfa inbakicept plus BCG for BCG-unresponsive bladder cancer faces implementation challenges due to ongoing BCG supply shortages across U.S. healthcare facilities. - Healthcare providers are adapting treatment strategies through split-dose BCG regimens and exploring alternative therapies, including nadofaragene firadenovec which offers convenient quarterly dosing schedules. - Novel diagnostic tools, including AI-powered pathology analysis and urinary cell-free DNA testing, are emerging as promising approaches for improving treatment selection and monitoring in bladder cancer.